... pathogenic variants in STAT3 occur most frequently in T-cell large granular lymphocyte leukemia [ Koskela et al 2012 ]. Somatic ... Cited Arora M, Bagi P, Strongin A, ...

... evidence for circulating Sézary cells is provided by T-cell receptor gene analysis, identification of the atypical ... Olsen EA, Rook AH, Zic J, et al.: ...

... Taguchi H, Yoshimoto S, et al. Inactivation of lymphocyte-transforming activity of human T-cell leukemia virus type I by heat. Japanese Journal of Cancer Research. 1986; 77 :13–5. [ PubMed : 3007413 ] Excluded studies 323 references were excluded at the full-text stage. Human ...

... can be elevated in any condition in which T-cell activation is present. Because ... by cytotoxic lymphocytes to kill target cells. Increased expression of granzyme ...

... by other organizations, see the ClinicalTrials.gov website . References ... Blood 105 (5): 1898-904, 2005. [ PubMed : 15542583 ] ...

... General information about clinical trials is also ... and donor lymphocyte infusion following salvage therapy with anti-CD52 monoclonal ...

... HL. Lymphocyte-rich classical HL. Mixed-cellularity ... Treatment References Zeppa P, Marino G, Troncone G, et al.: ...

... HL. Lymphocyte-rich classical HL. Mixed-cellularity ... Treatment References Zeppa P, Marino G, Troncone G, et al.: ...

... until disease progression or intolerable toxicity. Anti–cytotoxic T-lymphocyte antigen-4 (CTLA-4) Ipilimumab Ipilimumab is a human monoclonal antibody that binds to CTLA-4, thereby blocking its ability to downregulate T-cell activation, proliferation, and effector function. Approved by the ...

... of CD27 + memory B cells Decreased apoptosis of T lymphocytes in response to stimulation of the cell death ... protein expression by flow cytometry Increased apoptosis of T lymphocytes in response to stimulation of the cell death ...